Commercial and medical operations that work across markets
Strategic ClarityScalable Operating ModelsProfitable Growth
I help pharma and commercial-stage biotech leaders build or reset the way their teams deliver. We decide what to run globally, what stays with the markets and where partners can do the work better. I work alongside your team through rollout and stabilisation, until the model delivers its business case.
- Around 50% lower structural costs than the less centralised model it replaced. Built and scaled a global services platform for commercial and medical operations at Boehringer Ingelheim: 100+ markets and €75m+ annual operating budget.
- More than 40% growth in opt-in internal service sales. Grew sales across Novartis Region Europe, where internal customers chose whether to buy. Developed an internal strategic account from zero into a multi-million global services business within 2+ years.
Where companies usually bring me in
Every engagement has a common core: the operating model behind your commercial and medical operations. By operating model I mean how a customer need becomes a product or service, delivered at the right time, quality and cost, driven by three choices: the end-to-end process, make or buy, and location.
A big operating model decision is ahead.
You need to decide what to build or buy, what runs globally or stays in the markets, and which work moves to hubs near- or offshore.
Strategic ClarityYour business is growing faster than your operating model.
You’re adding markets or indications and need to decide how teams and partners will handle the extra work.
Scalable Operating ModelsYour costs are growing faster than your business.
Each new market or indication adds more cost than it should, vendor spend is fragmented, or markets work around the operating model.
Profitable GrowthHow to work with me
Bring me in for a defined transformation mandate or start with one decision. For a larger mandate, I agree the scope and outcomes with the sponsor and work alongside the team as the model is designed, rolled out and stabilised.
Who I work with
- Established pharma: commercial, medical and global services organisations that need to build or reset delivery across markets.
- Commercial-stage biotech and mid-sized pharma: teams adding markets or indications and planning how to handle the extra work.
Career
At Novartis and Boehringer Ingelheim from 2011 to 2025.
Next step: email me with the decision in front of you.
michael@kurradvisory.comStrategic ClarityScalable Operating ModelsProfitable Growth